-

Medable Announces its Continued Commitment to Global Privacy and Data Protection Through Earned CIPP/E Certification

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the end-to-end platform for digitally enabled and data-driven clinical trials, today announced that Andrea Sanchez, Vice President Legal & SaMD secured CIPP/E Certification.

A member of the State Bar of Texas and J.D. from Baylor Law School, Andrea earned the ANSI-accredited Certified Information Privacy Professional/Europe (CIPP/E) credential through the International Association of Privacy Professionals (IAPP). “As an attorney and privacy professional, Andrea already brings significant privacy and data protection capabilities to Medable. Recognition of Andrea’s knowledge and expertise via the CIPP/E credential further demonstrates Medable’s own commitment to privacy and data protection globally, and in particular, data protection in the EU.,” said Perry Robinson, Chief Legal & Compliance Officer at Medable.

Medable currently serves customers across the globe and continues to expand its service offerings in the clinical trial space and in its leadership position in the digital trial space.

In addition to the CIPP/E credential, Andrea holds the CIPP/US credential. The CIPP is the global standard in privacy certification. Developed and launched by the IAPP with leading subject matter experts, the CIPP is the world’s first broad-based global privacy and data protection credentialing program.

The CIPP/US demonstrates a strong foundation in U.S. private-sector privacy laws and regulations and an understanding of the legal requirements for the responsible transfer of sensitive personal data to/from the U.S., the EU, and other jurisdictions.

The CIPP/E is the first professional credential specific to European data protection professionals that is part of a comprehensive, principles-based framework and knowledge base in information privacy. The CIPP/E encompasses pan-European and national data protection laws, the European model for privacy enforcement, key privacy terminology and practical concepts concerning the protection of personal data and trans-border data flows. Andrea joins the ranks of professionals worldwide who currently hold one or more IAPP certifications.

About Medable

Medable is a privately held, venture-backed company headquartered in Palo Alto, California. Medable is on a mission to get effective therapies to patients faster by dramatically reducing the time from therapeutic development to market realization with digital data capture and real-time analytics that remove the complexities of clinical research to dramatically reduce trial timelines. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution. Medable’s end-to-end digital trial platform allows patients, healthcare providers, clinical research organizations and pharmaceutical sponsors to work together as a connected and empowered team in clinical trials and research.

Contacts

Investors
Medable
investors@medable.com

Media
Letitia Rodley, VP Marketing
Media@Medable.com

Medable Inc.

Details
Headquarters: Palo Alto, California
CEO: Michelle Longmire
Employees: 350
Organization: PRI

Release Summary
Medable announces its continued commitment to global privacy and data protection through earned CIPP/E certification
Release Versions

Contacts

Investors
Medable
investors@medable.com

Media
Letitia Rodley, VP Marketing
Media@Medable.com

Social Media Profiles
More News From Medable Inc.

Medable Launches Innovation Evidence Workshop – First Collaboration To Bring Leaders Together on DCT Impact, Adoption, and Best Practices

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable, the leading provider of AI-powered clinical trial technology, today announced its Innovation Evidence Workshop series, developed in collaboration with and facilitated by the Tufts Center for the Study of Drug Development (Tufts CSDD). Leaders from 20 pharmaceutical, biotech, and contract research organizations (CROs) participated in the inaugural invitation-only workshop held on November 19 in Boston, MA. Programming featured representatives from the...

Medable Named a Leader Amid Growing eCOA Adoption

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical trial technology, today announced it has been named a Leader in Everest Group’s 2025 "Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment." Medable was recognized among 19 vendors for its strong performance across three key areas: buyer priorities, innovation, and future focus. Medable was named a Leader for its continued investment in AI and machine learning to enhance plat...

Medable to Present at Morgan Stanley Global Healthcare Conference

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading AI technology platform provider for clinical research, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the Morgan Stanley Global Healthcare Conference in New York City. The presentation will take place on Tuesday, September 9th 7:45 AM Eastern Time. About Medable Medable, a Software as a Service (SaaS) cloud platform, is revolutionizing clinical drug development. Our AI-driven...
Back to Newsroom